D
iabetes mellitus is a well recognised risk factor for cardiovascular disease and diabetic individuals with acute coronary syndrome (ACS) have a two-to fourfold increased risk of adverse cardiovascular events compared to non-diabetic individuals. 1 It is becoming increasingly clear that impaired glucose metabolism and the pre-diabetic state are also associated with adverse clinical outcomes. A retrospective study of 197 patients by Norhammar et al 2 showed that among non-diabetic patients with acute myocardial infarction, those with higher admission blood glucose had higher rates of death, rehospitalisation for heart failure, and rehospitalisation for non-fatal reinfarction. In this study, admission plasma glucose was an independent predictor of non-fatal reinfarction, hospitalisation for heart failure, and a major adverse cardiovascular event (MACE). 2 Another study by Norhammar et al revealed that 35% of patients admitted to the coronary care unit with a myocardial infarction and no prior diagnosis of diabetes may have an abnormal glucose tolerance test at discharge. 3 The American Diabetes Association (ADA) recently redefined the cut off point for normal fasting blood glucose concentrations from 110 mg/dl to 100 mg/dl, meaning that a value of 100 mg/dl or above would lead to a diagnosis of impaired fasting glucose, which is included in the term prediabetes. 4 The impact of the new guideline is immense. Health and human services estimate that 40% of US adults aged 40-74 years, approximately 41 million people, have prediabetes. Under the previous criteria, it was estimated that 21 million people in this age group have pre-diabetes. We assessed the impact of the pre-diabetic state on clinical outcomes in patients presenting with ACS incorporating the new ADA definition.
METHODS
The primary objective was to analyse the prognostic implication of fasting glucose concentrations in ACS patients. We studied 1955 consecutive patients who were admitted to the University of Michigan Medical Center from January 1999 to August 2002 with a diagnosis of ACS. The protocol was approved by the institutional review board at the University of Michigan and informed consent was obtained from all patients.
All patients were initially identified by a discharge diagnosis of unstable angina or acute myocardial infarction. Identified charts were reviewed by nurses or physicians for entry criteria. Inclusion into the study required symptoms consistent with acute coronary insufficiency, along with one or more of the following: a history of coronary artery disease, electrocardiographic changes suggestive of ischaemia, evidence of coronary artery disease by catheterisation, and/or elevation of cardiac biomarkers. Clinical, demographic, treatment, and outcome data were abstracted from medical charts by trained abstractors (physicians and/or cardiology research nurses). Demographic variables included age and sex. Co-morbidities included prior history of heart disease (angina, heart failure, myocardial infarction, coronary artery bypass grafting, and percutaneous coronary intervention), diabetes, smoking, hyperlipidaemia, and hypertension. ECG changes and initial laboratory data including fasting plasma glucose were recorded. Procedures and complications during the ACS hospitalisation were documented.
Patients were stratified based on their fasting glucose concentrations as non-diabetic, pre-diabetic based on both the new and the old ADA definitions, and those with known diabetes. We compared in-hospital outcomes including death, reinfarction, stroke, cardiogenic shock, pulmonary oedema, cardiac arrest, atrial dysrhythmias, and the composite of MACE in the different categories.
Univariate statistics are presented as frequency and percentage for categorical variables, and mean (SD) for continuous variables. p Values for comparisons of the distributions of categorical variables between groups were based on x 2 tests. p Values for comparisons of continuous variables between diabetic and non-diabetic groups were based on t tests. A multivariable logistic regression analysis was performed for in-hospital MACE in ACS patients adjusted for age, sex, troponin elevation, ST segment elevation, serum creatinine, heart failure, and revascularisation. All analyses were performed using SAS 8.2 (SAS Institute, Cary, North Carolina, USA).
RESULTS
Patients with impaired fasting glucose or pre-diabetes were more likely to be male, have higher body mass index, have higher incidence of peripheral vascular disease, and a lower left ventricular ejection fraction ( fig 1) . Acute dyspnoea two days after chest pain A 78 year old woman presented to a local hospital 10 hours after onset of typical angina. Based on symptoms of acute chest pain, ST elevation in anterior leads, and elevated creatine phosphokinase (maximum value 450 U/l), the diagnosis of an acute anterior myocardial infarction (AMI) was made. Because of the circumstances a conservative management was pursued. Twenty four hours later, after initial recovery, the patient presented with acute dyspnoea caused by pulmonary oedema and had to be intubated. For further diagnostics and treatment she was transferred to our institution. Transthoracic and transoesophageal ultrasound showed a ruptured posterior papillary muscle (panel A). Coronary angiography revealed a mild three vessel disease with a relevant stenosis of the left anterior descending artery (LAD). Due to low output an intra-aortic balloon pump was inserted. Emergency mitral valve replacement (MVR) combined with revascularisation of the LAD was performed (panel B). The surgical procedure was well tolerated. Further recovery was complicated by progressive respiratory distress syndrome with pneumonia leading to death of the patient 10 days later.
This case illustrates the typical occurrence of a mechanical complication after a relatively small AMI. Mechanical complications following AMI occurs relatively rarely (2-3%), but need to be diagnosed and treated as quickly as possible. Mechanical complications should be considered in any patient deteriorating acutely after a preceding ischaemic myocardial event and initial stabilisation. Once the diagnosis of an ischaemic papillary muscle rupture is made, immediate surgical intervention should be considered and undertaken. 
